Aster DM Healthcare Ltd
BSE:540975
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
321.75
522.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Aster DM Healthcare Ltd
Aster DM Healthcare Ltd
Revenue
Aster DM Healthcare Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aster DM Healthcare Ltd
BSE:540975
|
Revenue
₹117.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Revenue
₹190.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Revenue
₹70.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Revenue
₹54.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Revenue
₹52.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Revenue
₹32.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aster DM Healthcare Ltd
Glance View
Aster DM Healthcare Ltd. engages in the provision of healthcare solutions. The company is headquartered in Bangalore, Karnataka and currently employs 24,653 full-time employees. The company went IPO on 2018-02-26. The firm's segments include Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment comprises of hospitals and in-house pharmacies at the hospitals. The Clinics segment comprises of clinics and in-house pharmacies at the clinics. The Retail Pharmacies segment comprises standalone retail pharmacies and optical outlets. The Other segment comprises healthcare consultancy services. Its geographical segments consist of gulf corporation council (GCC) States, including United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, and India. The firm's healthcare services are offered under Aster, Medcare and Access brands. The company operates over 32 hospitals, 127 clinics, 521 pharmacies (Including 255 Pharmacies in India operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 229 labs and patient experience centers in seven countries, including India.
See Also
What is Aster DM Healthcare Ltd's Revenue?
Revenue
117.3B
INR
Based on the financial report for Jun 30, 2024, Aster DM Healthcare Ltd's Revenue amounts to 117.3B INR.
What is Aster DM Healthcare Ltd's Revenue growth rate?
Revenue CAGR 5Y
7%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Aster DM Healthcare Ltd have been 8% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
